Table 4.
Neurologic abnormalities at presentation and after PEX began in 78 patients with their initial episode of TTP
Number of patients with neurologic abnormalities | ||||||
---|---|---|---|---|---|---|
Neurologic abnormalities | At presentation | After PEX began | Total neurologic abnormalities | |||
No. | % | No. | % | No. | % | |
None | 26 | 33 | 60 | 77 | 16 | 20 |
Minor | 20 | 26 | 2 | 3 | 21 | 27 |
Severe | 32 | 41 | 16 | 20 | 41 | 53 |
Coma | 2 | 3 | 4 | 5 | 6 | 8 |
Stroke | 6 | 8 | 4 | 5 | 9 | 12 |
Seizure | 6 | 8 | 7 | 9 | 12 | 15 |
Transient focal abnormalities | 26 | 35 | 10 | 10 | 31 | 40 |
Minor neurologic abnormalities were not recorded in patients who had severe neurologic abnormalities. Neurologic abnormalities documented after PEX began were distinct abnormalities. One patient had a recurrent minor abnormality after PEX began. Seven patients had distinct severe abnormalities both at presentation and after PEX began. Among the 4 categories of severe abnormalities, 17 of the 41 patients had abnormalities in multiple categories. One patient had an extension of her stroke after PEX began; 12 had seizures; 1 had seizures before PEX began and another seizure after her initial PEX; 31 had transient focal neurologic abnormalities; 5 had recurrent abnormalities (diplopia, aphasia, face/hand weakness/numbness) after PEX began; 19 had transient focal abnormalities as their only severe abnormality; and 12 had transient focal abnormalities in addition to seizures, stroke, and/or coma.